Akaal Pharma

09/09/2022

https://akaalpharma.com/akaal-pharma-pty-ltd-processed-the-national-phase-filing-of-its-drug-candidate-ak-119-and-s1p1-agonist-technology/

Greater Shepparton, Victoria, Australia, 9th September 2022. Akaal Pharma Pty Limited (Akaal Pharma) today announced that it has processed filing to national phase, including the major markets, of its international patent application (PCT). Earlier, Akaal had received a favourable international prel...

02/01/2021

Akaal Pharma multimodal action topical products are in development to address the major unmet needs in skin diseases and related bothersome symptoms pruritus. Pruritus is largely unmet medical need and could be acute or chronic in various skin ailments such as xerosis, atopic dermatitis (AD), prurigo nodularis and perianal eczema.

We are also developing a pipeline of oral pain and immune modulators for autoimmune diseases and neuropathic pain.

19/12/2018

Akaal Pharma Announces Positive Results from Phase 1 Clinical Study of Novel Topical AKP-11 for the Treatment of Psoriasis.

19/12/2018

Akaal Pharma Pty Ltd Announces Licensing Agreement for its First-in-Class, Topical Spingosine-1-Phosphate-1 (S1P1) Receptor Modulator for Atopic Dermatitis and Psoriasis.

Akaal Pharma Pty Limited (Akaal Pharma) today announced that it has entered into a licensing agreement for Akaal Pharma’s First-in-Class, topical Spin

06/08/2017

Akaal Pharma Initiates Phase-2 of -11 for the of (Eczema)

AKP-11 demonstrated efficacy, safety and tolerability in Phase-1. AKP-11 offers new potential topical treatment of moderate-to-severe atopic dermatitis.

12/01/2017

Akaal Pharma to Attend 35th J. P. Morgan Healthcare Conference
#2017

12/01/2017

Akaal Pharma to Attend 35th J. P. Morgan Healthcare Conference
#2017

http://www.akaalpharma.com/download/akaal-pharma-at-35th-JP-Morgan-conf-9-Jan-2017.pdf

15/09/2016

Japan Patent Granted to Akaal Pharma on S1P1 Receptor Modulators for Immune and Inflammatory Diseases...

24/06/2016

25/02/2016

About the 9th Annual ELSCEO Forum & Exhibition...